SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Debt Conversion, Converted Instrument, Rate
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Debt Conversion, Converted Instrument, Rate of 50.00% as of 2022-03-11, per its 10-K filed 2023-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentRate · last filed 2023-03-15
- 2022-03-11: Debt Conversion, Converted Instrument, Rate 50.00%.
- 2022-02-08: Debt Conversion, Converted Instrument, Rate 50.00%.
| Period end | Debt Conversion, Converted Instrument, Rate |
|---|---|
| 2022-03-11 | 50.00% 10-K · filed 2023-03-15 |
| 2022-02-08 | 50.00% 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |